Global Parkinson’s Disease Therapeutics Market Research Report 2024, Forecast to 2032
Report Overview
Parkinson's disease therapeutics includes medications and therapies used to manage the symptoms of Parkinson's disease, a neurodegenerative disorder that affects movement and motor control.
The global Parkinson’s Disease Therapeutics market size was estimated at USD 2337.80 million in 2023 and is projected to reach USD 3949.66 million by 2032, exhibiting a CAGR of 6.00% during the forecast period.
North America Parkinson’s Disease Therapeutics market size was estimated at USD 673.43 million in 2023, at a CAGR of 5.14% during the forecast period of 2024 through 2032.
This report provides a deep insight into the global Parkinson’s Disease Therapeutics market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Parkinson’s Disease Therapeutics Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Parkinson’s Disease Therapeutics market in any manner.
Global Parkinson’s Disease Therapeutics Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Abbvie
Biogen
Boehringer Ingelheim GmbH
F. Hoffman-La Roche
GlaxoSmithKline
H. Lundbeck A/S
Impax Labs
Newron Pharmaceuticals SpA
Novartis AG
Orion Corporation
Teva Pharmaceutical Industries Ltd.
UCB S.A.
Livzon Pharmaceutical
Haisco Pharmaceutical
Jingxin Pharmaceutical
Dongcheng Biochemicals
Market Segmentation (by Type)
Oral
Transdermal
Subcutaneous
Intestinal Infusion
Market Segmentation (by Application)
Hospitals
Clinics
Others
Geographic Segmentation
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Parkinson’s Disease Therapeutics Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region from the consumer side and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Parkinson’s Disease Therapeutics, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region during the forecast period.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment during the forecast period.
Chapter 13 is the main points and conclusions of the report.
Parkinson's disease therapeutics includes medications and therapies used to manage the symptoms of Parkinson's disease, a neurodegenerative disorder that affects movement and motor control.
The global Parkinson’s Disease Therapeutics market size was estimated at USD 2337.80 million in 2023 and is projected to reach USD 3949.66 million by 2032, exhibiting a CAGR of 6.00% during the forecast period.
North America Parkinson’s Disease Therapeutics market size was estimated at USD 673.43 million in 2023, at a CAGR of 5.14% during the forecast period of 2024 through 2032.
This report provides a deep insight into the global Parkinson’s Disease Therapeutics market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Parkinson’s Disease Therapeutics Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Parkinson’s Disease Therapeutics market in any manner.
Global Parkinson’s Disease Therapeutics Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Abbvie
Biogen
Boehringer Ingelheim GmbH
F. Hoffman-La Roche
GlaxoSmithKline
H. Lundbeck A/S
Impax Labs
Newron Pharmaceuticals SpA
Novartis AG
Orion Corporation
Teva Pharmaceutical Industries Ltd.
UCB S.A.
Livzon Pharmaceutical
Haisco Pharmaceutical
Jingxin Pharmaceutical
Dongcheng Biochemicals
Market Segmentation (by Type)
Oral
Transdermal
Subcutaneous
Intestinal Infusion
Market Segmentation (by Application)
Hospitals
Clinics
Others
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Parkinson’s Disease Therapeutics Market
- Overview of the regional outlook of the Parkinson’s Disease Therapeutics Market:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Parkinson’s Disease Therapeutics Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region from the consumer side and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Parkinson’s Disease Therapeutics, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region during the forecast period.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment during the forecast period.
Chapter 13 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Parkinson’s Disease Therapeutics
1.2 Key Market Segments
1.2.1 Parkinson’s Disease Therapeutics Segment by Type
1.2.2 Parkinson’s Disease Therapeutics Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 PARKINSON’S DISEASE THERAPEUTICS MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Parkinson’s Disease Therapeutics Market Size (M USD) Estimates and Forecasts (2019-2032)
2.1.2 Global Parkinson’s Disease Therapeutics Sales Estimates and Forecasts (2019-2032)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 PARKINSON’S DISEASE THERAPEUTICS MARKET COMPETITIVE LANDSCAPE
3.1 Global Parkinson’s Disease Therapeutics Sales by Manufacturers (2019-2024)
3.2 Global Parkinson’s Disease Therapeutics Revenue Market Share by Manufacturers (2019-2024)
3.3 Parkinson’s Disease Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Parkinson’s Disease Therapeutics Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Parkinson’s Disease Therapeutics Sales Sites, Area Served, Product Type
3.6 Parkinson’s Disease Therapeutics Market Competitive Situation and Trends
3.6.1 Parkinson’s Disease Therapeutics Market Concentration Rate
3.6.2 Global 5 and 10 Largest Parkinson’s Disease Therapeutics Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 PARKINSON’S DISEASE THERAPEUTICS INDUSTRY CHAIN ANALYSIS
4.1 Parkinson’s Disease Therapeutics Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF PARKINSON’S DISEASE THERAPEUTICS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 PARKINSON’S DISEASE THERAPEUTICS MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Parkinson’s Disease Therapeutics Sales Market Share by Type (2019-2024)
6.3 Global Parkinson’s Disease Therapeutics Market Size Market Share by Type (2019-2024)
6.4 Global Parkinson’s Disease Therapeutics Price by Type (2019-2024)
7 PARKINSON’S DISEASE THERAPEUTICS MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Parkinson’s Disease Therapeutics Market Sales by Application (2019-2024)
7.3 Global Parkinson’s Disease Therapeutics Market Size (M USD) by Application (2019-2024)
7.4 Global Parkinson’s Disease Therapeutics Sales Growth Rate by Application (2019-2024)
8 PARKINSON’S DISEASE THERAPEUTICS MARKET CONSUMPTION BY REGION
8.1 Global Parkinson’s Disease Therapeutics Sales by Region
8.1.1 Global Parkinson’s Disease Therapeutics Sales by Region
8.1.2 Global Parkinson’s Disease Therapeutics Sales Market Share by Region
8.2 North America
8.2.1 North America Parkinson’s Disease Therapeutics Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Parkinson’s Disease Therapeutics Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Parkinson’s Disease Therapeutics Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Parkinson’s Disease Therapeutics Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Parkinson’s Disease Therapeutics Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 PARKINSON’S DISEASE THERAPEUTICS MARKET PRODUCTION BY REGION
9.1 Global Production of Parkinson’s Disease Therapeutics by Region (2019-2024)
9.2 Global Parkinson’s Disease Therapeutics Revenue Market Share by Region (2019-2024)
9.3 Global Parkinson’s Disease Therapeutics Production, Revenue, Price and Gross Margin (2019-2024)
9.4 North America Parkinson’s Disease Therapeutics Production
9.4.1 North America Parkinson’s Disease Therapeutics Production Growth Rate (2019-2024)
9.4.2 North America Parkinson’s Disease Therapeutics Production, Revenue, Price and Gross Margin (2019-2024)
9.5 Europe Parkinson’s Disease Therapeutics Production
9.5.1 Europe Parkinson’s Disease Therapeutics Production Growth Rate (2019-2024)
9.5.2 Europe Parkinson’s Disease Therapeutics Production, Revenue, Price and Gross Margin (2019-2024)
9.6 Japan Parkinson’s Disease Therapeutics Production (2019-2024)
9.6.1 Japan Parkinson’s Disease Therapeutics Production Growth Rate (2019-2024)
9.6.2 Japan Parkinson’s Disease Therapeutics Production, Revenue, Price and Gross Margin (2019-2024)
9.7 China Parkinson’s Disease Therapeutics Production (2019-2024)
9.7.1 China Parkinson’s Disease Therapeutics Production Growth Rate (2019-2024)
9.7.2 China Parkinson’s Disease Therapeutics Production, Revenue, Price and Gross Margin (2019-2024)
10 KEY COMPANIES PROFILE
10.1 Abbvie
10.1.1 Abbvie Parkinson’s Disease Therapeutics Basic Information
10.1.2 Abbvie Parkinson’s Disease Therapeutics Product Overview
10.1.3 Abbvie Parkinson’s Disease Therapeutics Product Market Performance
10.1.4 Abbvie Business Overview
10.1.5 Abbvie Parkinson’s Disease Therapeutics SWOT Analysis
10.1.6 Abbvie Recent Developments
10.2 Biogen
10.2.1 Biogen Parkinson’s Disease Therapeutics Basic Information
10.2.2 Biogen Parkinson’s Disease Therapeutics Product Overview
10.2.3 Biogen Parkinson’s Disease Therapeutics Product Market Performance
10.2.4 Biogen Business Overview
10.2.5 Biogen Parkinson’s Disease Therapeutics SWOT Analysis
10.2.6 Biogen Recent Developments
10.3 Boehringer Ingelheim GmbH
10.3.1 Boehringer Ingelheim GmbH Parkinson’s Disease Therapeutics Basic Information
10.3.2 Boehringer Ingelheim GmbH Parkinson’s Disease Therapeutics Product Overview
10.3.3 Boehringer Ingelheim GmbH Parkinson’s Disease Therapeutics Product Market Performance
10.3.4 Boehringer Ingelheim GmbH Parkinson’s Disease Therapeutics SWOT Analysis
10.3.5 Boehringer Ingelheim GmbH Business Overview
10.3.6 Boehringer Ingelheim GmbH Recent Developments
10.4 F. Hoffman-La Roche
10.4.1 F. Hoffman-La Roche Parkinson’s Disease Therapeutics Basic Information
10.4.2 F. Hoffman-La Roche Parkinson’s Disease Therapeutics Product Overview
10.4.3 F. Hoffman-La Roche Parkinson’s Disease Therapeutics Product Market Performance
10.4.4 F. Hoffman-La Roche Business Overview
10.4.5 F. Hoffman-La Roche Recent Developments
10.5 GlaxoSmithKline
10.5.1 GlaxoSmithKline Parkinson’s Disease Therapeutics Basic Information
10.5.2 GlaxoSmithKline Parkinson’s Disease Therapeutics Product Overview
10.5.3 GlaxoSmithKline Parkinson’s Disease Therapeutics Product Market Performance
10.5.4 GlaxoSmithKline Business Overview
10.5.5 GlaxoSmithKline Recent Developments
10.6 H. Lundbeck A/S
10.6.1 H. Lundbeck A/S Parkinson’s Disease Therapeutics Basic Information
10.6.2 H. Lundbeck A/S Parkinson’s Disease Therapeutics Product Overview
10.6.3 H. Lundbeck A/S Parkinson’s Disease Therapeutics Product Market Performance
10.6.4 H. Lundbeck A/S Business Overview
10.6.5 H. Lundbeck A/S Recent Developments
10.7 Impax Labs
10.7.1 Impax Labs Parkinson’s Disease Therapeutics Basic Information
10.7.2 Impax Labs Parkinson’s Disease Therapeutics Product Overview
10.7.3 Impax Labs Parkinson’s Disease Therapeutics Product Market Performance
10.7.4 Impax Labs Business Overview
10.7.5 Impax Labs Recent Developments
10.8 Newron Pharmaceuticals SpA
10.8.1 Newron Pharmaceuticals SpA Parkinson’s Disease Therapeutics Basic Information
10.8.2 Newron Pharmaceuticals SpA Parkinson’s Disease Therapeutics Product Overview
10.8.3 Newron Pharmaceuticals SpA Parkinson’s Disease Therapeutics Product Market Performance
10.8.4 Newron Pharmaceuticals SpA Business Overview
10.8.5 Newron Pharmaceuticals SpA Recent Developments
10.9 Novartis AG
10.9.1 Novartis AG Parkinson’s Disease Therapeutics Basic Information
10.9.2 Novartis AG Parkinson’s Disease Therapeutics Product Overview
10.9.3 Novartis AG Parkinson’s Disease Therapeutics Product Market Performance
10.9.4 Novartis AG Business Overview
10.9.5 Novartis AG Recent Developments
10.10 Orion Corporation
10.10.1 Orion Corporation Parkinson’s Disease Therapeutics Basic Information
10.10.2 Orion Corporation Parkinson’s Disease Therapeutics Product Overview
10.10.3 Orion Corporation Parkinson’s Disease Therapeutics Product Market Performance
10.10.4 Orion Corporation Business Overview
10.10.5 Orion Corporation Recent Developments
10.11 Teva Pharmaceutical Industries Ltd.
10.11.1 Teva Pharmaceutical Industries Ltd. Parkinson’s Disease Therapeutics Basic Information
10.11.2 Teva Pharmaceutical Industries Ltd. Parkinson’s Disease Therapeutics Product Overview
10.11.3 Teva Pharmaceutical Industries Ltd. Parkinson’s Disease Therapeutics Product Market Performance
10.11.4 Teva Pharmaceutical Industries Ltd. Business Overview
10.11.5 Teva Pharmaceutical Industries Ltd. Recent Developments
10.12 UCB S.A.
10.12.1 UCB S.A. Parkinson’s Disease Therapeutics Basic Information
10.12.2 UCB S.A. Parkinson’s Disease Therapeutics Product Overview
10.12.3 UCB S.A. Parkinson’s Disease Therapeutics Product Market Performance
10.12.4 UCB S.A. Business Overview
10.12.5 UCB S.A. Recent Developments
10.13 Livzon Pharmaceutical
10.13.1 Livzon Pharmaceutical Parkinson’s Disease Therapeutics Basic Information
10.13.2 Livzon Pharmaceutical Parkinson’s Disease Therapeutics Product Overview
10.13.3 Livzon Pharmaceutical Parkinson’s Disease Therapeutics Product Market Performance
10.13.4 Livzon Pharmaceutical Business Overview
10.13.5 Livzon Pharmaceutical Recent Developments
10.14 Haisco Pharmaceutical
10.14.1 Haisco Pharmaceutical Parkinson’s Disease Therapeutics Basic Information
10.14.2 Haisco Pharmaceutical Parkinson’s Disease Therapeutics Product Overview
10.14.3 Haisco Pharmaceutical Parkinson’s Disease Therapeutics Product Market Performance
10.14.4 Haisco Pharmaceutical Business Overview
10.14.5 Haisco Pharmaceutical Recent Developments
10.15 Jingxin Pharmaceutical
10.15.1 Jingxin Pharmaceutical Parkinson’s Disease Therapeutics Basic Information
10.15.2 Jingxin Pharmaceutical Parkinson’s Disease Therapeutics Product Overview
10.15.3 Jingxin Pharmaceutical Parkinson’s Disease Therapeutics Product Market Performance
10.15.4 Jingxin Pharmaceutical Business Overview
10.15.5 Jingxin Pharmaceutical Recent Developments
10.16 Dongcheng Biochemicals
10.16.1 Dongcheng Biochemicals Parkinson’s Disease Therapeutics Basic Information
10.16.2 Dongcheng Biochemicals Parkinson’s Disease Therapeutics Product Overview
10.16.3 Dongcheng Biochemicals Parkinson’s Disease Therapeutics Product Market Performance
10.16.4 Dongcheng Biochemicals Business Overview
10.16.5 Dongcheng Biochemicals Recent Developments
11 PARKINSON’S DISEASE THERAPEUTICS MARKET FORECAST BY REGION
11.1 Global Parkinson’s Disease Therapeutics Market Size Forecast
11.2 Global Parkinson’s Disease Therapeutics Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Parkinson’s Disease Therapeutics Market Size Forecast by Country
11.2.3 Asia Pacific Parkinson’s Disease Therapeutics Market Size Forecast by Region
11.2.4 South America Parkinson’s Disease Therapeutics Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Consumption of Parkinson’s Disease Therapeutics by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2032)
12.1 Global Parkinson’s Disease Therapeutics Market Forecast by Type (2025-2032)
12.1.1 Global Forecasted Sales of Parkinson’s Disease Therapeutics by Type (2025-2032)
12.1.2 Global Parkinson’s Disease Therapeutics Market Size Forecast by Type (2025-2032)
12.1.3 Global Forecasted Price of Parkinson’s Disease Therapeutics by Type (2025-2032)
12.2 Global Parkinson’s Disease Therapeutics Market Forecast by Application (2025-2032)
12.2.1 Global Parkinson’s Disease Therapeutics Sales (K MT) Forecast by Application
12.2.2 Global Parkinson’s Disease Therapeutics Market Size (M USD) Forecast by Application (2025-2032)
13 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Parkinson’s Disease Therapeutics
1.2 Key Market Segments
1.2.1 Parkinson’s Disease Therapeutics Segment by Type
1.2.2 Parkinson’s Disease Therapeutics Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 PARKINSON’S DISEASE THERAPEUTICS MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Parkinson’s Disease Therapeutics Market Size (M USD) Estimates and Forecasts (2019-2032)
2.1.2 Global Parkinson’s Disease Therapeutics Sales Estimates and Forecasts (2019-2032)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 PARKINSON’S DISEASE THERAPEUTICS MARKET COMPETITIVE LANDSCAPE
3.1 Global Parkinson’s Disease Therapeutics Sales by Manufacturers (2019-2024)
3.2 Global Parkinson’s Disease Therapeutics Revenue Market Share by Manufacturers (2019-2024)
3.3 Parkinson’s Disease Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Parkinson’s Disease Therapeutics Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Parkinson’s Disease Therapeutics Sales Sites, Area Served, Product Type
3.6 Parkinson’s Disease Therapeutics Market Competitive Situation and Trends
3.6.1 Parkinson’s Disease Therapeutics Market Concentration Rate
3.6.2 Global 5 and 10 Largest Parkinson’s Disease Therapeutics Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 PARKINSON’S DISEASE THERAPEUTICS INDUSTRY CHAIN ANALYSIS
4.1 Parkinson’s Disease Therapeutics Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF PARKINSON’S DISEASE THERAPEUTICS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 PARKINSON’S DISEASE THERAPEUTICS MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Parkinson’s Disease Therapeutics Sales Market Share by Type (2019-2024)
6.3 Global Parkinson’s Disease Therapeutics Market Size Market Share by Type (2019-2024)
6.4 Global Parkinson’s Disease Therapeutics Price by Type (2019-2024)
7 PARKINSON’S DISEASE THERAPEUTICS MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Parkinson’s Disease Therapeutics Market Sales by Application (2019-2024)
7.3 Global Parkinson’s Disease Therapeutics Market Size (M USD) by Application (2019-2024)
7.4 Global Parkinson’s Disease Therapeutics Sales Growth Rate by Application (2019-2024)
8 PARKINSON’S DISEASE THERAPEUTICS MARKET CONSUMPTION BY REGION
8.1 Global Parkinson’s Disease Therapeutics Sales by Region
8.1.1 Global Parkinson’s Disease Therapeutics Sales by Region
8.1.2 Global Parkinson’s Disease Therapeutics Sales Market Share by Region
8.2 North America
8.2.1 North America Parkinson’s Disease Therapeutics Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Parkinson’s Disease Therapeutics Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Parkinson’s Disease Therapeutics Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Parkinson’s Disease Therapeutics Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Parkinson’s Disease Therapeutics Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 PARKINSON’S DISEASE THERAPEUTICS MARKET PRODUCTION BY REGION
9.1 Global Production of Parkinson’s Disease Therapeutics by Region (2019-2024)
9.2 Global Parkinson’s Disease Therapeutics Revenue Market Share by Region (2019-2024)
9.3 Global Parkinson’s Disease Therapeutics Production, Revenue, Price and Gross Margin (2019-2024)
9.4 North America Parkinson’s Disease Therapeutics Production
9.4.1 North America Parkinson’s Disease Therapeutics Production Growth Rate (2019-2024)
9.4.2 North America Parkinson’s Disease Therapeutics Production, Revenue, Price and Gross Margin (2019-2024)
9.5 Europe Parkinson’s Disease Therapeutics Production
9.5.1 Europe Parkinson’s Disease Therapeutics Production Growth Rate (2019-2024)
9.5.2 Europe Parkinson’s Disease Therapeutics Production, Revenue, Price and Gross Margin (2019-2024)
9.6 Japan Parkinson’s Disease Therapeutics Production (2019-2024)
9.6.1 Japan Parkinson’s Disease Therapeutics Production Growth Rate (2019-2024)
9.6.2 Japan Parkinson’s Disease Therapeutics Production, Revenue, Price and Gross Margin (2019-2024)
9.7 China Parkinson’s Disease Therapeutics Production (2019-2024)
9.7.1 China Parkinson’s Disease Therapeutics Production Growth Rate (2019-2024)
9.7.2 China Parkinson’s Disease Therapeutics Production, Revenue, Price and Gross Margin (2019-2024)
10 KEY COMPANIES PROFILE
10.1 Abbvie
10.1.1 Abbvie Parkinson’s Disease Therapeutics Basic Information
10.1.2 Abbvie Parkinson’s Disease Therapeutics Product Overview
10.1.3 Abbvie Parkinson’s Disease Therapeutics Product Market Performance
10.1.4 Abbvie Business Overview
10.1.5 Abbvie Parkinson’s Disease Therapeutics SWOT Analysis
10.1.6 Abbvie Recent Developments
10.2 Biogen
10.2.1 Biogen Parkinson’s Disease Therapeutics Basic Information
10.2.2 Biogen Parkinson’s Disease Therapeutics Product Overview
10.2.3 Biogen Parkinson’s Disease Therapeutics Product Market Performance
10.2.4 Biogen Business Overview
10.2.5 Biogen Parkinson’s Disease Therapeutics SWOT Analysis
10.2.6 Biogen Recent Developments
10.3 Boehringer Ingelheim GmbH
10.3.1 Boehringer Ingelheim GmbH Parkinson’s Disease Therapeutics Basic Information
10.3.2 Boehringer Ingelheim GmbH Parkinson’s Disease Therapeutics Product Overview
10.3.3 Boehringer Ingelheim GmbH Parkinson’s Disease Therapeutics Product Market Performance
10.3.4 Boehringer Ingelheim GmbH Parkinson’s Disease Therapeutics SWOT Analysis
10.3.5 Boehringer Ingelheim GmbH Business Overview
10.3.6 Boehringer Ingelheim GmbH Recent Developments
10.4 F. Hoffman-La Roche
10.4.1 F. Hoffman-La Roche Parkinson’s Disease Therapeutics Basic Information
10.4.2 F. Hoffman-La Roche Parkinson’s Disease Therapeutics Product Overview
10.4.3 F. Hoffman-La Roche Parkinson’s Disease Therapeutics Product Market Performance
10.4.4 F. Hoffman-La Roche Business Overview
10.4.5 F. Hoffman-La Roche Recent Developments
10.5 GlaxoSmithKline
10.5.1 GlaxoSmithKline Parkinson’s Disease Therapeutics Basic Information
10.5.2 GlaxoSmithKline Parkinson’s Disease Therapeutics Product Overview
10.5.3 GlaxoSmithKline Parkinson’s Disease Therapeutics Product Market Performance
10.5.4 GlaxoSmithKline Business Overview
10.5.5 GlaxoSmithKline Recent Developments
10.6 H. Lundbeck A/S
10.6.1 H. Lundbeck A/S Parkinson’s Disease Therapeutics Basic Information
10.6.2 H. Lundbeck A/S Parkinson’s Disease Therapeutics Product Overview
10.6.3 H. Lundbeck A/S Parkinson’s Disease Therapeutics Product Market Performance
10.6.4 H. Lundbeck A/S Business Overview
10.6.5 H. Lundbeck A/S Recent Developments
10.7 Impax Labs
10.7.1 Impax Labs Parkinson’s Disease Therapeutics Basic Information
10.7.2 Impax Labs Parkinson’s Disease Therapeutics Product Overview
10.7.3 Impax Labs Parkinson’s Disease Therapeutics Product Market Performance
10.7.4 Impax Labs Business Overview
10.7.5 Impax Labs Recent Developments
10.8 Newron Pharmaceuticals SpA
10.8.1 Newron Pharmaceuticals SpA Parkinson’s Disease Therapeutics Basic Information
10.8.2 Newron Pharmaceuticals SpA Parkinson’s Disease Therapeutics Product Overview
10.8.3 Newron Pharmaceuticals SpA Parkinson’s Disease Therapeutics Product Market Performance
10.8.4 Newron Pharmaceuticals SpA Business Overview
10.8.5 Newron Pharmaceuticals SpA Recent Developments
10.9 Novartis AG
10.9.1 Novartis AG Parkinson’s Disease Therapeutics Basic Information
10.9.2 Novartis AG Parkinson’s Disease Therapeutics Product Overview
10.9.3 Novartis AG Parkinson’s Disease Therapeutics Product Market Performance
10.9.4 Novartis AG Business Overview
10.9.5 Novartis AG Recent Developments
10.10 Orion Corporation
10.10.1 Orion Corporation Parkinson’s Disease Therapeutics Basic Information
10.10.2 Orion Corporation Parkinson’s Disease Therapeutics Product Overview
10.10.3 Orion Corporation Parkinson’s Disease Therapeutics Product Market Performance
10.10.4 Orion Corporation Business Overview
10.10.5 Orion Corporation Recent Developments
10.11 Teva Pharmaceutical Industries Ltd.
10.11.1 Teva Pharmaceutical Industries Ltd. Parkinson’s Disease Therapeutics Basic Information
10.11.2 Teva Pharmaceutical Industries Ltd. Parkinson’s Disease Therapeutics Product Overview
10.11.3 Teva Pharmaceutical Industries Ltd. Parkinson’s Disease Therapeutics Product Market Performance
10.11.4 Teva Pharmaceutical Industries Ltd. Business Overview
10.11.5 Teva Pharmaceutical Industries Ltd. Recent Developments
10.12 UCB S.A.
10.12.1 UCB S.A. Parkinson’s Disease Therapeutics Basic Information
10.12.2 UCB S.A. Parkinson’s Disease Therapeutics Product Overview
10.12.3 UCB S.A. Parkinson’s Disease Therapeutics Product Market Performance
10.12.4 UCB S.A. Business Overview
10.12.5 UCB S.A. Recent Developments
10.13 Livzon Pharmaceutical
10.13.1 Livzon Pharmaceutical Parkinson’s Disease Therapeutics Basic Information
10.13.2 Livzon Pharmaceutical Parkinson’s Disease Therapeutics Product Overview
10.13.3 Livzon Pharmaceutical Parkinson’s Disease Therapeutics Product Market Performance
10.13.4 Livzon Pharmaceutical Business Overview
10.13.5 Livzon Pharmaceutical Recent Developments
10.14 Haisco Pharmaceutical
10.14.1 Haisco Pharmaceutical Parkinson’s Disease Therapeutics Basic Information
10.14.2 Haisco Pharmaceutical Parkinson’s Disease Therapeutics Product Overview
10.14.3 Haisco Pharmaceutical Parkinson’s Disease Therapeutics Product Market Performance
10.14.4 Haisco Pharmaceutical Business Overview
10.14.5 Haisco Pharmaceutical Recent Developments
10.15 Jingxin Pharmaceutical
10.15.1 Jingxin Pharmaceutical Parkinson’s Disease Therapeutics Basic Information
10.15.2 Jingxin Pharmaceutical Parkinson’s Disease Therapeutics Product Overview
10.15.3 Jingxin Pharmaceutical Parkinson’s Disease Therapeutics Product Market Performance
10.15.4 Jingxin Pharmaceutical Business Overview
10.15.5 Jingxin Pharmaceutical Recent Developments
10.16 Dongcheng Biochemicals
10.16.1 Dongcheng Biochemicals Parkinson’s Disease Therapeutics Basic Information
10.16.2 Dongcheng Biochemicals Parkinson’s Disease Therapeutics Product Overview
10.16.3 Dongcheng Biochemicals Parkinson’s Disease Therapeutics Product Market Performance
10.16.4 Dongcheng Biochemicals Business Overview
10.16.5 Dongcheng Biochemicals Recent Developments
11 PARKINSON’S DISEASE THERAPEUTICS MARKET FORECAST BY REGION
11.1 Global Parkinson’s Disease Therapeutics Market Size Forecast
11.2 Global Parkinson’s Disease Therapeutics Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Parkinson’s Disease Therapeutics Market Size Forecast by Country
11.2.3 Asia Pacific Parkinson’s Disease Therapeutics Market Size Forecast by Region
11.2.4 South America Parkinson’s Disease Therapeutics Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Consumption of Parkinson’s Disease Therapeutics by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2032)
12.1 Global Parkinson’s Disease Therapeutics Market Forecast by Type (2025-2032)
12.1.1 Global Forecasted Sales of Parkinson’s Disease Therapeutics by Type (2025-2032)
12.1.2 Global Parkinson’s Disease Therapeutics Market Size Forecast by Type (2025-2032)
12.1.3 Global Forecasted Price of Parkinson’s Disease Therapeutics by Type (2025-2032)
12.2 Global Parkinson’s Disease Therapeutics Market Forecast by Application (2025-2032)
12.2.1 Global Parkinson’s Disease Therapeutics Sales (K MT) Forecast by Application
12.2.2 Global Parkinson’s Disease Therapeutics Market Size (M USD) Forecast by Application (2025-2032)
13 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Parkinson’s Disease Therapeutics Market Size Comparison by Region (M USD)
Table 5. Global Parkinson’s Disease Therapeutics Sales (K MT) by Manufacturers (2019-2024)
Table 6. Global Parkinson’s Disease Therapeutics Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Parkinson’s Disease Therapeutics Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Parkinson’s Disease Therapeutics Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Parkinson’s Disease Therapeutics as of 2022)
Table 10. Global Market Parkinson’s Disease Therapeutics Average Price (USD/MT) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Parkinson’s Disease Therapeutics Sales Sites and Area Served
Table 12. Manufacturers Parkinson’s Disease Therapeutics Product Type
Table 13. Global Parkinson’s Disease Therapeutics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Parkinson’s Disease Therapeutics
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Parkinson’s Disease Therapeutics Market Challenges
Table 22. Global Parkinson’s Disease Therapeutics Sales by Type (K MT)
Table 23. Global Parkinson’s Disease Therapeutics Market Size by Type (M USD)
Table 24. Global Parkinson’s Disease Therapeutics Sales (K MT) by Type (2019-2024)
Table 25. Global Parkinson’s Disease Therapeutics Sales Market Share by Type (2019-2024)
Table 26. Global Parkinson’s Disease Therapeutics Market Size (M USD) by Type (2019-2024)
Table 27. Global Parkinson’s Disease Therapeutics Market Size Share by Type (2019-2024)
Table 28. Global Parkinson’s Disease Therapeutics Price (USD/MT) by Type (2019-2024)
Table 29. Global Parkinson’s Disease Therapeutics Sales (K MT) by Application
Table 30. Global Parkinson’s Disease Therapeutics Market Size by Application
Table 31. Global Parkinson’s Disease Therapeutics Sales by Application (2019-2024) & (K MT)
Table 32. Global Parkinson’s Disease Therapeutics Sales Market Share by Application (2019-2024)
Table 33. Global Parkinson’s Disease Therapeutics Sales by Application (2019-2024) & (M USD)
Table 34. Global Parkinson’s Disease Therapeutics Market Share by Application (2019-2024)
Table 35. Global Parkinson’s Disease Therapeutics Sales Growth Rate by Application (2019-2024)
Table 36. Global Parkinson’s Disease Therapeutics Sales by Region (2019-2024) & (K MT)
Table 37. Global Parkinson’s Disease Therapeutics Sales Market Share by Region (2019-2024)
Table 38. North America Parkinson’s Disease Therapeutics Sales by Country (2019-2024) & (K MT)
Table 39. Europe Parkinson’s Disease Therapeutics Sales by Country (2019-2024) & (K MT)
Table 40. Asia Pacific Parkinson’s Disease Therapeutics Sales by Region (2019-2024) & (K MT)
Table 41. South America Parkinson’s Disease Therapeutics Sales by Country (2019-2024) & (K MT)
Table 42. Middle East and Africa Parkinson’s Disease Therapeutics Sales by Region (2019-2024) & (K MT)
Table 43. Global Parkinson’s Disease Therapeutics Production (K MT) by Region (2019-2024)
Table 44. Global Parkinson’s Disease Therapeutics Revenue (US$ Million) by Region (2019-2024)
Table 45. Global Parkinson’s Disease Therapeutics Revenue Market Share by Region (2019-2024)
Table 46. Global Parkinson’s Disease Therapeutics Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 47. North America Parkinson’s Disease Therapeutics Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 48. Europe Parkinson’s Disease Therapeutics Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 49. Japan Parkinson’s Disease Therapeutics Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 50. China Parkinson’s Disease Therapeutics Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 51. Abbvie Parkinson’s Disease Therapeutics Basic Information
Table 52. Abbvie Parkinson’s Disease Therapeutics Product Overview
Table 53. Abbvie Parkinson’s Disease Therapeutics Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 54. Abbvie Business Overview
Table 55. Abbvie Parkinson’s Disease Therapeutics SWOT Analysis
Table 56. Abbvie Recent Developments
Table 57. Biogen Parkinson’s Disease Therapeutics Basic Information
Table 58. Biogen Parkinson’s Disease Therapeutics Product Overview
Table 59. Biogen Parkinson’s Disease Therapeutics Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 60. Biogen Business Overview
Table 61. Biogen Parkinson’s Disease Therapeutics SWOT Analysis
Table 62. Biogen Recent Developments
Table 63. Boehringer Ingelheim GmbH Parkinson’s Disease Therapeutics Basic Information
Table 64. Boehringer Ingelheim GmbH Parkinson’s Disease Therapeutics Product Overview
Table 65. Boehringer Ingelheim GmbH Parkinson’s Disease Therapeutics Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 66. Boehringer Ingelheim GmbH Parkinson’s Disease Therapeutics SWOT Analysis
Table 67. Boehringer Ingelheim GmbH Business Overview
Table 68. Boehringer Ingelheim GmbH Recent Developments
Table 69. F. Hoffman-La Roche Parkinson’s Disease Therapeutics Basic Information
Table 70. F. Hoffman-La Roche Parkinson’s Disease Therapeutics Product Overview
Table 71. F. Hoffman-La Roche Parkinson’s Disease Therapeutics Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 72. F. Hoffman-La Roche Business Overview
Table 73. F. Hoffman-La Roche Recent Developments
Table 74. GlaxoSmithKline Parkinson’s Disease Therapeutics Basic Information
Table 75. GlaxoSmithKline Parkinson’s Disease Therapeutics Product Overview
Table 76. GlaxoSmithKline Parkinson’s Disease Therapeutics Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 77. GlaxoSmithKline Business Overview
Table 78. GlaxoSmithKline Recent Developments
Table 79. H. Lundbeck A/S Parkinson’s Disease Therapeutics Basic Information
Table 80. H. Lundbeck A/S Parkinson’s Disease Therapeutics Product Overview
Table 81. H. Lundbeck A/S Parkinson’s Disease Therapeutics Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 82. H. Lundbeck A/S Business Overview
Table 83. H. Lundbeck A/S Recent Developments
Table 84. Impax Labs Parkinson’s Disease Therapeutics Basic Information
Table 85. Impax Labs Parkinson’s Disease Therapeutics Product Overview
Table 86. Impax Labs Parkinson’s Disease Therapeutics Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 87. Impax Labs Business Overview
Table 88. Impax Labs Recent Developments
Table 89. Newron Pharmaceuticals SpA Parkinson’s Disease Therapeutics Basic Information
Table 90. Newron Pharmaceuticals SpA Parkinson’s Disease Therapeutics Product Overview
Table 91. Newron Pharmaceuticals SpA Parkinson’s Disease Therapeutics Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 92. Newron Pharmaceuticals SpA Business Overview
Table 93. Newron Pharmaceuticals SpA Recent Developments
Table 94. Novartis AG Parkinson’s Disease Therapeutics Basic Information
Table 95. Novartis AG Parkinson’s Disease Therapeutics Product Overview
Table 96. Novartis AG Parkinson’s Disease Therapeutics Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 97. Novartis AG Business Overview
Table 98. Novartis AG Recent Developments
Table 99. Orion Corporation Parkinson’s Disease Therapeutics Basic Information
Table 100. Orion Corporation Parkinson’s Disease Therapeutics Product Overview
Table 101. Orion Corporation Parkinson’s Disease Therapeutics Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 102. Orion Corporation Business Overview
Table 103. Orion Corporation Recent Developments
Table 104. Teva Pharmaceutical Industries Ltd. Parkinson’s Disease Therapeutics Basic Information
Table 105. Teva Pharmaceutical Industries Ltd. Parkinson’s Disease Therapeutics Product Overview
Table 106. Teva Pharmaceutical Industries Ltd. Parkinson’s Disease Therapeutics Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 107. Teva Pharmaceutical Industries Ltd. Business Overview
Table 108. Teva Pharmaceutical Industries Ltd. Recent Developments
Table 109. UCB S.A. Parkinson’s Disease Therapeutics Basic Information
Table 110. UCB S.A. Parkinson’s Disease Therapeutics Product Overview
Table 111. UCB S.A. Parkinson’s Disease Therapeutics Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 112. UCB S.A. Business Overview
Table 113. UCB S.A. Recent Developments
Table 114. Livzon Pharmaceutical Parkinson’s Disease Therapeutics Basic Information
Table 115. Livzon Pharmaceutical Parkinson’s Disease Therapeutics Product Overview
Table 116. Livzon Pharmaceutical Parkinson’s Disease Therapeutics Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 117. Livzon Pharmaceutical Business Overview
Table 118. Livzon Pharmaceutical Recent Developments
Table 119. Haisco Pharmaceutical Parkinson’s Disease Therapeutics Basic Information
Table 120. Haisco Pharmaceutical Parkinson’s Disease Therapeutics Product Overview
Table 121. Haisco Pharmaceutical Parkinson’s Disease Therapeutics Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 122. Haisco Pharmaceutical Business Overview
Table 123. Haisco Pharmaceutical Recent Developments
Table 124. Jingxin Pharmaceutical Parkinson’s Disease Therapeutics Basic Information
Table 125. Jingxin Pharmaceutical Parkinson’s Disease Therapeutics Product Overview
Table 126. Jingxin Pharmaceutical Parkinson’s Disease Therapeutics Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 127. Jingxin Pharmaceutical Business Overview
Table 128. Jingxin Pharmaceutical Recent Developments
Table 129. Dongcheng Biochemicals Parkinson’s Disease Therapeutics Basic Information
Table 130. Dongcheng Biochemicals Parkinson’s Disease Therapeutics Product Overview
Table 131. Dongcheng Biochemicals Parkinson’s Disease Therapeutics Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 132. Dongcheng Biochemicals Business Overview
Table 133. Dongcheng Biochemicals Recent Developments
Table 134. Global Parkinson’s Disease Therapeutics Sales Forecast by Region (2025-2032) & (K MT)
Table 135. Global Parkinson’s Disease Therapeutics Market Size Forecast by Region (2025-2032) & (M USD)
Table 136. North America Parkinson’s Disease Therapeutics Sales Forecast by Country (2025-2032) & (K MT)
Table 137. North America Parkinson’s Disease Therapeutics Market Size Forecast by Country (2025-2032) & (M USD)
Table 138. Europe Parkinson’s Disease Therapeutics Sales Forecast by Country (2025-2032) & (K MT)
Table 139. Europe Parkinson’s Disease Therapeutics Market Size Forecast by Country (2025-2032) & (M USD)
Table 140. Asia Pacific Parkinson’s Disease Therapeutics Sales Forecast by Region (2025-2032) & (K MT)
Table 141. Asia Pacific Parkinson’s Disease Therapeutics Market Size Forecast by Region (2025-2032) & (M USD)
Table 142. South America Parkinson’s Disease Therapeutics Sales Forecast by Country (2025-2032) & (K MT)
Table 143. South America Parkinson’s Disease Therapeutics Market Size Forecast by Country (2025-2032) & (M USD)
Table 144. Middle East and Africa Parkinson’s Disease Therapeutics Consumption Forecast by Country (2025-2032) & (Units)
Table 145. Middle East and Africa Parkinson’s Disease Therapeutics Market Size Forecast by Country (2025-2032) & (M USD)
Table 146. Global Parkinson’s Disease Therapeutics Sales Forecast by Type (2025-2032) & (K MT)
Table 147. Global Parkinson’s Disease Therapeutics Market Size Forecast by Type (2025-2032) & (M USD)
Table 148. Global Parkinson’s Disease Therapeutics Price Forecast by Type (2025-2032) & (USD/MT)
Table 149. Global Parkinson’s Disease Therapeutics Sales (K MT) Forecast by Application (2025-2032)
Table 150. Global Parkinson’s Disease Therapeutics Market Size Forecast by Application (2025-2032) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Parkinson’s Disease Therapeutics Market Size Comparison by Region (M USD)
Table 5. Global Parkinson’s Disease Therapeutics Sales (K MT) by Manufacturers (2019-2024)
Table 6. Global Parkinson’s Disease Therapeutics Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Parkinson’s Disease Therapeutics Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Parkinson’s Disease Therapeutics Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Parkinson’s Disease Therapeutics as of 2022)
Table 10. Global Market Parkinson’s Disease Therapeutics Average Price (USD/MT) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Parkinson’s Disease Therapeutics Sales Sites and Area Served
Table 12. Manufacturers Parkinson’s Disease Therapeutics Product Type
Table 13. Global Parkinson’s Disease Therapeutics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Parkinson’s Disease Therapeutics
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Parkinson’s Disease Therapeutics Market Challenges
Table 22. Global Parkinson’s Disease Therapeutics Sales by Type (K MT)
Table 23. Global Parkinson’s Disease Therapeutics Market Size by Type (M USD)
Table 24. Global Parkinson’s Disease Therapeutics Sales (K MT) by Type (2019-2024)
Table 25. Global Parkinson’s Disease Therapeutics Sales Market Share by Type (2019-2024)
Table 26. Global Parkinson’s Disease Therapeutics Market Size (M USD) by Type (2019-2024)
Table 27. Global Parkinson’s Disease Therapeutics Market Size Share by Type (2019-2024)
Table 28. Global Parkinson’s Disease Therapeutics Price (USD/MT) by Type (2019-2024)
Table 29. Global Parkinson’s Disease Therapeutics Sales (K MT) by Application
Table 30. Global Parkinson’s Disease Therapeutics Market Size by Application
Table 31. Global Parkinson’s Disease Therapeutics Sales by Application (2019-2024) & (K MT)
Table 32. Global Parkinson’s Disease Therapeutics Sales Market Share by Application (2019-2024)
Table 33. Global Parkinson’s Disease Therapeutics Sales by Application (2019-2024) & (M USD)
Table 34. Global Parkinson’s Disease Therapeutics Market Share by Application (2019-2024)
Table 35. Global Parkinson’s Disease Therapeutics Sales Growth Rate by Application (2019-2024)
Table 36. Global Parkinson’s Disease Therapeutics Sales by Region (2019-2024) & (K MT)
Table 37. Global Parkinson’s Disease Therapeutics Sales Market Share by Region (2019-2024)
Table 38. North America Parkinson’s Disease Therapeutics Sales by Country (2019-2024) & (K MT)
Table 39. Europe Parkinson’s Disease Therapeutics Sales by Country (2019-2024) & (K MT)
Table 40. Asia Pacific Parkinson’s Disease Therapeutics Sales by Region (2019-2024) & (K MT)
Table 41. South America Parkinson’s Disease Therapeutics Sales by Country (2019-2024) & (K MT)
Table 42. Middle East and Africa Parkinson’s Disease Therapeutics Sales by Region (2019-2024) & (K MT)
Table 43. Global Parkinson’s Disease Therapeutics Production (K MT) by Region (2019-2024)
Table 44. Global Parkinson’s Disease Therapeutics Revenue (US$ Million) by Region (2019-2024)
Table 45. Global Parkinson’s Disease Therapeutics Revenue Market Share by Region (2019-2024)
Table 46. Global Parkinson’s Disease Therapeutics Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 47. North America Parkinson’s Disease Therapeutics Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 48. Europe Parkinson’s Disease Therapeutics Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 49. Japan Parkinson’s Disease Therapeutics Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 50. China Parkinson’s Disease Therapeutics Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 51. Abbvie Parkinson’s Disease Therapeutics Basic Information
Table 52. Abbvie Parkinson’s Disease Therapeutics Product Overview
Table 53. Abbvie Parkinson’s Disease Therapeutics Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 54. Abbvie Business Overview
Table 55. Abbvie Parkinson’s Disease Therapeutics SWOT Analysis
Table 56. Abbvie Recent Developments
Table 57. Biogen Parkinson’s Disease Therapeutics Basic Information
Table 58. Biogen Parkinson’s Disease Therapeutics Product Overview
Table 59. Biogen Parkinson’s Disease Therapeutics Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 60. Biogen Business Overview
Table 61. Biogen Parkinson’s Disease Therapeutics SWOT Analysis
Table 62. Biogen Recent Developments
Table 63. Boehringer Ingelheim GmbH Parkinson’s Disease Therapeutics Basic Information
Table 64. Boehringer Ingelheim GmbH Parkinson’s Disease Therapeutics Product Overview
Table 65. Boehringer Ingelheim GmbH Parkinson’s Disease Therapeutics Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 66. Boehringer Ingelheim GmbH Parkinson’s Disease Therapeutics SWOT Analysis
Table 67. Boehringer Ingelheim GmbH Business Overview
Table 68. Boehringer Ingelheim GmbH Recent Developments
Table 69. F. Hoffman-La Roche Parkinson’s Disease Therapeutics Basic Information
Table 70. F. Hoffman-La Roche Parkinson’s Disease Therapeutics Product Overview
Table 71. F. Hoffman-La Roche Parkinson’s Disease Therapeutics Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 72. F. Hoffman-La Roche Business Overview
Table 73. F. Hoffman-La Roche Recent Developments
Table 74. GlaxoSmithKline Parkinson’s Disease Therapeutics Basic Information
Table 75. GlaxoSmithKline Parkinson’s Disease Therapeutics Product Overview
Table 76. GlaxoSmithKline Parkinson’s Disease Therapeutics Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 77. GlaxoSmithKline Business Overview
Table 78. GlaxoSmithKline Recent Developments
Table 79. H. Lundbeck A/S Parkinson’s Disease Therapeutics Basic Information
Table 80. H. Lundbeck A/S Parkinson’s Disease Therapeutics Product Overview
Table 81. H. Lundbeck A/S Parkinson’s Disease Therapeutics Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 82. H. Lundbeck A/S Business Overview
Table 83. H. Lundbeck A/S Recent Developments
Table 84. Impax Labs Parkinson’s Disease Therapeutics Basic Information
Table 85. Impax Labs Parkinson’s Disease Therapeutics Product Overview
Table 86. Impax Labs Parkinson’s Disease Therapeutics Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 87. Impax Labs Business Overview
Table 88. Impax Labs Recent Developments
Table 89. Newron Pharmaceuticals SpA Parkinson’s Disease Therapeutics Basic Information
Table 90. Newron Pharmaceuticals SpA Parkinson’s Disease Therapeutics Product Overview
Table 91. Newron Pharmaceuticals SpA Parkinson’s Disease Therapeutics Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 92. Newron Pharmaceuticals SpA Business Overview
Table 93. Newron Pharmaceuticals SpA Recent Developments
Table 94. Novartis AG Parkinson’s Disease Therapeutics Basic Information
Table 95. Novartis AG Parkinson’s Disease Therapeutics Product Overview
Table 96. Novartis AG Parkinson’s Disease Therapeutics Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 97. Novartis AG Business Overview
Table 98. Novartis AG Recent Developments
Table 99. Orion Corporation Parkinson’s Disease Therapeutics Basic Information
Table 100. Orion Corporation Parkinson’s Disease Therapeutics Product Overview
Table 101. Orion Corporation Parkinson’s Disease Therapeutics Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 102. Orion Corporation Business Overview
Table 103. Orion Corporation Recent Developments
Table 104. Teva Pharmaceutical Industries Ltd. Parkinson’s Disease Therapeutics Basic Information
Table 105. Teva Pharmaceutical Industries Ltd. Parkinson’s Disease Therapeutics Product Overview
Table 106. Teva Pharmaceutical Industries Ltd. Parkinson’s Disease Therapeutics Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 107. Teva Pharmaceutical Industries Ltd. Business Overview
Table 108. Teva Pharmaceutical Industries Ltd. Recent Developments
Table 109. UCB S.A. Parkinson’s Disease Therapeutics Basic Information
Table 110. UCB S.A. Parkinson’s Disease Therapeutics Product Overview
Table 111. UCB S.A. Parkinson’s Disease Therapeutics Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 112. UCB S.A. Business Overview
Table 113. UCB S.A. Recent Developments
Table 114. Livzon Pharmaceutical Parkinson’s Disease Therapeutics Basic Information
Table 115. Livzon Pharmaceutical Parkinson’s Disease Therapeutics Product Overview
Table 116. Livzon Pharmaceutical Parkinson’s Disease Therapeutics Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 117. Livzon Pharmaceutical Business Overview
Table 118. Livzon Pharmaceutical Recent Developments
Table 119. Haisco Pharmaceutical Parkinson’s Disease Therapeutics Basic Information
Table 120. Haisco Pharmaceutical Parkinson’s Disease Therapeutics Product Overview
Table 121. Haisco Pharmaceutical Parkinson’s Disease Therapeutics Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 122. Haisco Pharmaceutical Business Overview
Table 123. Haisco Pharmaceutical Recent Developments
Table 124. Jingxin Pharmaceutical Parkinson’s Disease Therapeutics Basic Information
Table 125. Jingxin Pharmaceutical Parkinson’s Disease Therapeutics Product Overview
Table 126. Jingxin Pharmaceutical Parkinson’s Disease Therapeutics Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 127. Jingxin Pharmaceutical Business Overview
Table 128. Jingxin Pharmaceutical Recent Developments
Table 129. Dongcheng Biochemicals Parkinson’s Disease Therapeutics Basic Information
Table 130. Dongcheng Biochemicals Parkinson’s Disease Therapeutics Product Overview
Table 131. Dongcheng Biochemicals Parkinson’s Disease Therapeutics Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 132. Dongcheng Biochemicals Business Overview
Table 133. Dongcheng Biochemicals Recent Developments
Table 134. Global Parkinson’s Disease Therapeutics Sales Forecast by Region (2025-2032) & (K MT)
Table 135. Global Parkinson’s Disease Therapeutics Market Size Forecast by Region (2025-2032) & (M USD)
Table 136. North America Parkinson’s Disease Therapeutics Sales Forecast by Country (2025-2032) & (K MT)
Table 137. North America Parkinson’s Disease Therapeutics Market Size Forecast by Country (2025-2032) & (M USD)
Table 138. Europe Parkinson’s Disease Therapeutics Sales Forecast by Country (2025-2032) & (K MT)
Table 139. Europe Parkinson’s Disease Therapeutics Market Size Forecast by Country (2025-2032) & (M USD)
Table 140. Asia Pacific Parkinson’s Disease Therapeutics Sales Forecast by Region (2025-2032) & (K MT)
Table 141. Asia Pacific Parkinson’s Disease Therapeutics Market Size Forecast by Region (2025-2032) & (M USD)
Table 142. South America Parkinson’s Disease Therapeutics Sales Forecast by Country (2025-2032) & (K MT)
Table 143. South America Parkinson’s Disease Therapeutics Market Size Forecast by Country (2025-2032) & (M USD)
Table 144. Middle East and Africa Parkinson’s Disease Therapeutics Consumption Forecast by Country (2025-2032) & (Units)
Table 145. Middle East and Africa Parkinson’s Disease Therapeutics Market Size Forecast by Country (2025-2032) & (M USD)
Table 146. Global Parkinson’s Disease Therapeutics Sales Forecast by Type (2025-2032) & (K MT)
Table 147. Global Parkinson’s Disease Therapeutics Market Size Forecast by Type (2025-2032) & (M USD)
Table 148. Global Parkinson’s Disease Therapeutics Price Forecast by Type (2025-2032) & (USD/MT)
Table 149. Global Parkinson’s Disease Therapeutics Sales (K MT) Forecast by Application (2025-2032)
Table 150. Global Parkinson’s Disease Therapeutics Market Size Forecast by Application (2025-2032) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Parkinson’s Disease Therapeutics
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Parkinson’s Disease Therapeutics Market Size (M USD), 2019-2032
Figure 5. Global Parkinson’s Disease Therapeutics Market Size (M USD) (2019-2032)
Figure 6. Global Parkinson’s Disease Therapeutics Sales (K MT) & (2019-2032)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Parkinson’s Disease Therapeutics Market Size by Country (M USD)
Figure 11. Parkinson’s Disease Therapeutics Sales Share by Manufacturers in 2023
Figure 12. Global Parkinson’s Disease Therapeutics Revenue Share by Manufacturers in 2023
Figure 13. Parkinson’s Disease Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Parkinson’s Disease Therapeutics Average Price (USD/MT) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Parkinson’s Disease Therapeutics Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Parkinson’s Disease Therapeutics Market Share by Type
Figure 18. Sales Market Share of Parkinson’s Disease Therapeutics by Type (2019-2024)
Figure 19. Sales Market Share of Parkinson’s Disease Therapeutics by Type in 2023
Figure 20. Market Size Share of Parkinson’s Disease Therapeutics by Type (2019-2024)
Figure 21. Market Size Market Share of Parkinson’s Disease Therapeutics by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Parkinson’s Disease Therapeutics Market Share by Application
Figure 24. Global Parkinson’s Disease Therapeutics Sales Market Share by Application (2019-2024)
Figure 25. Global Parkinson’s Disease Therapeutics Sales Market Share by Application in 2023
Figure 26. Global Parkinson’s Disease Therapeutics Market Share by Application (2019-2024)
Figure 27. Global Parkinson’s Disease Therapeutics Market Share by Application in 2023
Figure 28. Global Parkinson’s Disease Therapeutics Sales Growth Rate by Application (2019-2024)
Figure 29. Global Parkinson’s Disease Therapeutics Sales Market Share by Region (2019-2024)
Figure 30. North America Parkinson’s Disease Therapeutics Sales and Growth Rate (2019-2024) & (K MT)
Figure 31. North America Parkinson’s Disease Therapeutics Sales Market Share by Country in 2023
Figure 32. U.S. Parkinson’s Disease Therapeutics Sales and Growth Rate (2019-2024) & (K MT)
Figure 33. Canada Parkinson’s Disease Therapeutics Sales (K MT) and Growth Rate (2019-2024)
Figure 34. Mexico Parkinson’s Disease Therapeutics Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Parkinson’s Disease Therapeutics Sales and Growth Rate (2019-2024) & (K MT)
Figure 36. Europe Parkinson’s Disease Therapeutics Sales Market Share by Country in 2023
Figure 37. Germany Parkinson’s Disease Therapeutics Sales and Growth Rate (2019-2024) & (K MT)
Figure 38. France Parkinson’s Disease Therapeutics Sales and Growth Rate (2019-2024) & (K MT)
Figure 39. U.K. Parkinson’s Disease Therapeutics Sales and Growth Rate (2019-2024) & (K MT)
Figure 40. Italy Parkinson’s Disease Therapeutics Sales and Growth Rate (2019-2024) & (K MT)
Figure 41. Russia Parkinson’s Disease Therapeutics Sales and Growth Rate (2019-2024) & (K MT)
Figure 42. Asia Pacific Parkinson’s Disease Therapeutics Sales and Growth Rate (K MT)
Figure 43. Asia Pacific Parkinson’s Disease Therapeutics Sales Market Share by Region in 2023
Figure 44. China Parkinson’s Disease Therapeutics Sales and Growth Rate (2019-2024) & (K MT)
Figure 45. Japan Parkinson’s Disease Therapeutics Sales and Growth Rate (2019-2024) & (K MT)
Figure 46. South Korea Parkinson’s Disease Therapeutics Sales and Growth Rate (2019-2024) & (K MT)
Figure 47. India Parkinson’s Disease Therapeutics Sales and Growth Rate (2019-2024) & (K MT)
Figure 48. Southeast Asia Parkinson’s Disease Therapeutics Sales and Growth Rate (2019-2024) & (K MT)
Figure 49. South America Parkinson’s Disease Therapeutics Sales and Growth Rate (K MT)
Figure 50. South America Parkinson’s Disease Therapeutics Sales Market Share by Country in 2023
Figure 51. Brazil Parkinson’s Disease Therapeutics Sales and Growth Rate (2019-2024) & (K MT)
Figure 52. Argentina Parkinson’s Disease Therapeutics Sales and Growth Rate (2019-2024) & (K MT)
Figure 53. Columbia Parkinson’s Disease Therapeutics Sales and Growth Rate (2019-2024) & (K MT)
Figure 54. Middle East and Africa Parkinson’s Disease Therapeutics Sales and Growth Rate (K MT)
Figure 55. Middle East and Africa Parkinson’s Disease Therapeutics Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Parkinson’s Disease Therapeutics Sales and Growth Rate (2019-2024) & (K MT)
Figure 57. UAE Parkinson’s Disease Therapeutics Sales and Growth Rate (2019-2024) & (K MT)
Figure 58. Egypt Parkinson’s Disease Therapeutics Sales and Growth Rate (2019-2024) & (K MT)
Figure 59. Nigeria Parkinson’s Disease Therapeutics Sales and Growth Rate (2019-2024) & (K MT)
Figure 60. South Africa Parkinson’s Disease Therapeutics Sales and Growth Rate (2019-2024) & (K MT)
Figure 61. Global Parkinson’s Disease Therapeutics Production Market Share by Region (2019-2024)
Figure 62. North America Parkinson’s Disease Therapeutics Production (K MT) Growth Rate (2019-2024)
Figure 63. Europe Parkinson’s Disease Therapeutics Production (K MT) Growth Rate (2019-2024)
Figure 64. Japan Parkinson’s Disease Therapeutics Production (K MT) Growth Rate (2019-2024)
Figure 65. China Parkinson’s Disease Therapeutics Production (K MT) Growth Rate (2019-2024)
Figure 66. Global Parkinson’s Disease Therapeutics Sales Forecast by Volume (2019-2032) & (K MT)
Figure 67. Global Parkinson’s Disease Therapeutics Market Size Forecast by Value (2019-2032) & (M USD)
Figure 68. Global Parkinson’s Disease Therapeutics Sales Market Share Forecast by Type (2025-2032)
Figure 69. Global Parkinson’s Disease Therapeutics Market Share Forecast by Type (2025-2032)
Figure 70. Global Parkinson’s Disease Therapeutics Sales Forecast by Application (2025-2032)
Figure 71. Global Parkinson’s Disease Therapeutics Market Share Forecast by Application (2025-2032)
Figure 1. Product Picture of Parkinson’s Disease Therapeutics
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Parkinson’s Disease Therapeutics Market Size (M USD), 2019-2032
Figure 5. Global Parkinson’s Disease Therapeutics Market Size (M USD) (2019-2032)
Figure 6. Global Parkinson’s Disease Therapeutics Sales (K MT) & (2019-2032)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Parkinson’s Disease Therapeutics Market Size by Country (M USD)
Figure 11. Parkinson’s Disease Therapeutics Sales Share by Manufacturers in 2023
Figure 12. Global Parkinson’s Disease Therapeutics Revenue Share by Manufacturers in 2023
Figure 13. Parkinson’s Disease Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Parkinson’s Disease Therapeutics Average Price (USD/MT) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Parkinson’s Disease Therapeutics Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Parkinson’s Disease Therapeutics Market Share by Type
Figure 18. Sales Market Share of Parkinson’s Disease Therapeutics by Type (2019-2024)
Figure 19. Sales Market Share of Parkinson’s Disease Therapeutics by Type in 2023
Figure 20. Market Size Share of Parkinson’s Disease Therapeutics by Type (2019-2024)
Figure 21. Market Size Market Share of Parkinson’s Disease Therapeutics by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Parkinson’s Disease Therapeutics Market Share by Application
Figure 24. Global Parkinson’s Disease Therapeutics Sales Market Share by Application (2019-2024)
Figure 25. Global Parkinson’s Disease Therapeutics Sales Market Share by Application in 2023
Figure 26. Global Parkinson’s Disease Therapeutics Market Share by Application (2019-2024)
Figure 27. Global Parkinson’s Disease Therapeutics Market Share by Application in 2023
Figure 28. Global Parkinson’s Disease Therapeutics Sales Growth Rate by Application (2019-2024)
Figure 29. Global Parkinson’s Disease Therapeutics Sales Market Share by Region (2019-2024)
Figure 30. North America Parkinson’s Disease Therapeutics Sales and Growth Rate (2019-2024) & (K MT)
Figure 31. North America Parkinson’s Disease Therapeutics Sales Market Share by Country in 2023
Figure 32. U.S. Parkinson’s Disease Therapeutics Sales and Growth Rate (2019-2024) & (K MT)
Figure 33. Canada Parkinson’s Disease Therapeutics Sales (K MT) and Growth Rate (2019-2024)
Figure 34. Mexico Parkinson’s Disease Therapeutics Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Parkinson’s Disease Therapeutics Sales and Growth Rate (2019-2024) & (K MT)
Figure 36. Europe Parkinson’s Disease Therapeutics Sales Market Share by Country in 2023
Figure 37. Germany Parkinson’s Disease Therapeutics Sales and Growth Rate (2019-2024) & (K MT)
Figure 38. France Parkinson’s Disease Therapeutics Sales and Growth Rate (2019-2024) & (K MT)
Figure 39. U.K. Parkinson’s Disease Therapeutics Sales and Growth Rate (2019-2024) & (K MT)
Figure 40. Italy Parkinson’s Disease Therapeutics Sales and Growth Rate (2019-2024) & (K MT)
Figure 41. Russia Parkinson’s Disease Therapeutics Sales and Growth Rate (2019-2024) & (K MT)
Figure 42. Asia Pacific Parkinson’s Disease Therapeutics Sales and Growth Rate (K MT)
Figure 43. Asia Pacific Parkinson’s Disease Therapeutics Sales Market Share by Region in 2023
Figure 44. China Parkinson’s Disease Therapeutics Sales and Growth Rate (2019-2024) & (K MT)
Figure 45. Japan Parkinson’s Disease Therapeutics Sales and Growth Rate (2019-2024) & (K MT)
Figure 46. South Korea Parkinson’s Disease Therapeutics Sales and Growth Rate (2019-2024) & (K MT)
Figure 47. India Parkinson’s Disease Therapeutics Sales and Growth Rate (2019-2024) & (K MT)
Figure 48. Southeast Asia Parkinson’s Disease Therapeutics Sales and Growth Rate (2019-2024) & (K MT)
Figure 49. South America Parkinson’s Disease Therapeutics Sales and Growth Rate (K MT)
Figure 50. South America Parkinson’s Disease Therapeutics Sales Market Share by Country in 2023
Figure 51. Brazil Parkinson’s Disease Therapeutics Sales and Growth Rate (2019-2024) & (K MT)
Figure 52. Argentina Parkinson’s Disease Therapeutics Sales and Growth Rate (2019-2024) & (K MT)
Figure 53. Columbia Parkinson’s Disease Therapeutics Sales and Growth Rate (2019-2024) & (K MT)
Figure 54. Middle East and Africa Parkinson’s Disease Therapeutics Sales and Growth Rate (K MT)
Figure 55. Middle East and Africa Parkinson’s Disease Therapeutics Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Parkinson’s Disease Therapeutics Sales and Growth Rate (2019-2024) & (K MT)
Figure 57. UAE Parkinson’s Disease Therapeutics Sales and Growth Rate (2019-2024) & (K MT)
Figure 58. Egypt Parkinson’s Disease Therapeutics Sales and Growth Rate (2019-2024) & (K MT)
Figure 59. Nigeria Parkinson’s Disease Therapeutics Sales and Growth Rate (2019-2024) & (K MT)
Figure 60. South Africa Parkinson’s Disease Therapeutics Sales and Growth Rate (2019-2024) & (K MT)
Figure 61. Global Parkinson’s Disease Therapeutics Production Market Share by Region (2019-2024)
Figure 62. North America Parkinson’s Disease Therapeutics Production (K MT) Growth Rate (2019-2024)
Figure 63. Europe Parkinson’s Disease Therapeutics Production (K MT) Growth Rate (2019-2024)
Figure 64. Japan Parkinson’s Disease Therapeutics Production (K MT) Growth Rate (2019-2024)
Figure 65. China Parkinson’s Disease Therapeutics Production (K MT) Growth Rate (2019-2024)
Figure 66. Global Parkinson’s Disease Therapeutics Sales Forecast by Volume (2019-2032) & (K MT)
Figure 67. Global Parkinson’s Disease Therapeutics Market Size Forecast by Value (2019-2032) & (M USD)
Figure 68. Global Parkinson’s Disease Therapeutics Sales Market Share Forecast by Type (2025-2032)
Figure 69. Global Parkinson’s Disease Therapeutics Market Share Forecast by Type (2025-2032)
Figure 70. Global Parkinson’s Disease Therapeutics Sales Forecast by Application (2025-2032)
Figure 71. Global Parkinson’s Disease Therapeutics Market Share Forecast by Application (2025-2032)
